Evidence map›Paper›PMID 23863605›Full record

ArticleVirulence2013

Constant domains influence binding of mouse-human chimeric antibodies to the capsular polypeptide of Bacillus anthracis.

Mark A Hubbard, Peter Thorkildson, Thomas R Kozel, David P AuCoin

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mark A HubbardDepartment of Microbiology and Immunology; University of Nevada School of Medicine, Reno, NV, USA. daucoin@medicine.nevada.edu
Peter Thorkildson
Thomas R Kozel
David P AuCoin
University of Nevada, Reno · US

Funding

B. anthracis:passive immunization with anticapsular mAbR01AI059348 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 2004 to 2012
$3.5M
Immunoassay for capsular antigen for rapid diagnosis of anthraxR01AI093365 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 2011 to 2015
$3.4M
NIAID NIH HHS R01 AI059348NIAID NIH HHS R01 AI093365NIAID NIH HHS R01AI093365PHS HHS R01SAI059348
6 · The paper itself

Abstract

Our laboratory previously described the binding characteristics of the murine IgG3 monoclonal antibody (MuAb) F26G3. This antibody binds the poly-glutamic acid capsule (PGA) of Bacillus anthracis, an essential virulence factor in the progression of anthrax. F26G3 IgG3 MuAb binds PGA with a relatively high functional affinity (10 nM), produces a distinct "rim" quellung reaction, and is protective in a murine model of pulmonary anthrax. This study engineered an IgG subclass family of F26G3 mouse-human chimeric antibodies (ChAb). The F26G3 ChAbs displayed 9- to 20-fold decreases in functional affinity, as compared with the parent IgG3 MuAb. Additionally, the quellung reactions that were produced by the ChAbs all differed from the parent IgG3 MuAb in that they appeared "puffy" in nature. This study demonstrates that human constant domains may influence multiple facets of antibody binding to microbial capsular antigens despite their spatial separation from the traditional antigen-binding site.

Indexed as

AnimalsAnthraxAntibodies, BacterialAntibodies, Monoclonal, HumanizedBacillus anthracisBacterial CapsulesHumansKineticsMicePeptidesProtein Structure, TertiaryAntibodies, BacterialAntibodies, Monoclonal, HumanizedPeptidesaffinityBacillus anthraciscapsulechimeric antibodyquellung reactionspr

Identifiers

PMID23863605
PMCPMC5359726
OpenAlexW2048386832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.